Pursuant to Regulation 30 of SEBI (LODR), Regulations, 2015, Resignation of Mr. Bharat Kumar Bohra is tendered from the post of Company Secretary & Compliance Officer.
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Mr. Bharat Kumar Bohra has resigned from the post of Company Secretary and Compliance Officer of Clinitech Laboratory Ltd with effect from June 2, 2025. He cited 'better future prospects and other professional commitments' as the reason for stepping down. The company has informed the BSE about this change under SEBI Listing Regulations. The Managing Director, Mr. Jagdish Umakant Nayak, has signed the intimation.
The Company Secretary is a Key Managerial Personnel, so shareholders should expect a replacement to be appointed soon to ensure regulatory compliance is maintained. This is a routine KMP-level change and is unlikely to have a material impact on the stock price, though it temporarily leaves a key compliance role vacant.